Related Experiment Video
Updated: Aug 11, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Switching clozapine responders to olanzapine
K H Littrell1, C G Johnson, N M Hilligoss
1Promedica Research Center, Tucker, GA 30084, USA. promedica@aol.com
Converting from clozapine to olanzapine in schizophrenia patients maintained symptom control while reducing adverse effects. This switch offers a viable option for those experiencing clozapine-induced side effects.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Neuroscience
Background:
- Clozapine is an atypical antipsychotic for treatment-resistant schizophrenia.
- Clozapine use is limited by risks of agranulocytosis, seizures, sedation, and weight gain.
- Adverse effects often necessitate alternative treatments for clozapine responders.
Purpose of the Study:
- To evaluate the efficacy and safety of slow cross-titration from clozapine to olanzapine.
- To assess outcomes in clozapine-responsive patients experiencing medication-induced adverse events.
Main Methods:
- 20 outpatients with schizophrenia or schizoaffective disorder were converted from clozapine to olanzapine.
- Patients were clozapine-responsive but sought alternatives due to side effects.
- Symptomatology, mood, subjective response, and safety were monitored.
Main Results:
- Olanzapine demonstrated equivalent efficacy to clozapine in 90% of patients.
- No rehospitalizations or suicidal behavior were observed post-conversion.
- A reduction in drug-induced side effects and improved subjective response were noted.
Conclusions:
- Successful conversion from clozapine to olanzapine can reduce side effects while maintaining symptom control.
- This strategy offers significant patient benefits.
- Further research into clozapine-to-olanzapine conversion is warranted.
More Related Videos
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
13:18Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications